Ackman’s Big Move: Pershing Square Files to Go Public on the NYSE

With input from CNBC, the Wall Street Journal, Business Insider, Bloomberg, the Financial Times, Market Watch, Forbes, and Reuters.

Bill Ackman’s hedge fund is trying to go mainstream. Bill Ackman filed paperwork to list his firm, Pershing Square Capital Management, on the New York Stock Exchange. The twist: it’s a paired offering — Pershing Square’s common stock and shares of its closed-end vehicle, Pershing Square USA (PSUS), would both trade on the NYSE under a dual-listing setup.

Here’s the play: PSUS would be sold at $50 a pop, with Ackman aiming to raise between $5 billion and $10 billion for that fund. Buyers of PSUS in the IPO would also get a sweetener — 20 shares of Pershing Square common for every 100 PSUS shares, at no extra cost. The filing says Pershing Square already has roughly $2.8 billion in backing from family offices, pensions, insurers and ultra-wealthy investors ahead of the deal.

Ackman’s shop runs a tight, concentrated portfolio — about $30 billion under management — with notable stakes in names like Brookfield, Uber and Amazon. The dual listing is structured so the two securities trade separately but side-by-side, letting retail and institutional investors pick their exposure.

This isn’t Ackman’s first ride at the IPO rodeo — an earlier plan to raise up to $25 billion fell apart in 2024 — but the team pivoted, beefing up stakes in companies like Howard Hughes Holdings as part of a longer-term, permanent-capital strategy. Ackman’s looking to marry activist investing with a Buffett-style permanent-capital vehicle that’s easier for Main Street to buy into.

Expect fireworks when the numbers hit the market: the filing outlines the conversion and share math, the pre-commitments, and how the combined structure would work. If all goes through, Pershing Square says PSUS will be its first fund marketed to both retail and institutionals — a direct play on Ackman’s public profile (he’s also built a big following on X).

Ackman wants to give ordinary investors a seat at his concentrated-bet table. Whether the market bites depends on appetite for big active funds, the IPO pricing, and how comfortable investors are with the structural quirks of a dual-listed setup.